A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP
Status:
Completed
Trial end date:
2017-05-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety and pharmacokinetics of
intravenous nemonoxacin compared with intravenous moxifloxacin in adult patients with
community-acquired pneumonia (CAP).